Extract

The primary purpose of this study is to evaluate the safety, side effects, and dosage for Motexafin Gadolinium given with the chemotherapy drug docetaxel to patients with advanced cancers. Secondly, tumor response to the combined treatment, drug levels in the body, and drug interactions will be evaluated.

Inclusion criteria

• Breast Neoplasms ,Ovarian Neoplasms ,Prostatic Neoplasms ,Lung Neoplasms ,Gastrointestinal Neoplasms

Links

• ictrp
• nct